 Lorna Browne
Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 34 | 2025 | 3566 | 3.780 |
Why?
| | Tomography, X-Ray Computed | 19 | 2025 | 2691 | 3.070 |
Why?
| | Heart Defects, Congenital | 9 | 2025 | 842 | 2.360 |
Why?
| | Computed Tomography Angiography | 6 | 2025 | 129 | 1.990 |
Why?
| | Magnetic Resonance Angiography | 9 | 2025 | 240 | 1.980 |
Why?
| | Vascular Stiffness | 12 | 2024 | 494 | 1.800 |
Why?
| | Magnetic Resonance Imaging, Cine | 12 | 2024 | 193 | 1.650 |
Why?
| | Aortic Coarctation | 5 | 2025 | 83 | 1.620 |
Why?
| | Hemodynamics | 17 | 2024 | 1113 | 1.510 |
Why?
| | Hypertension, Pulmonary | 9 | 2024 | 1910 | 1.350 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 4 | 2022 | 91 | 1.350 |
Why?
| | Radiation Dosage | 4 | 2025 | 179 | 1.270 |
Why?
| | Coronary Angiography | 3 | 2025 | 317 | 1.140 |
Why?
| | Aorta | 12 | 2024 | 417 | 1.130 |
Why?
| | Child | 55 | 2025 | 21935 | 1.110 |
Why?
| | Pulmonary Artery | 12 | 2024 | 1086 | 1.100 |
Why?
| | Coronary Vessels | 5 | 2022 | 248 | 1.070 |
Why?
| | Infant | 27 | 2025 | 9465 | 1.010 |
Why?
| | Retrospective Studies | 34 | 2025 | 15657 | 0.940 |
Why?
| | Imaging, Three-Dimensional | 9 | 2025 | 580 | 0.920 |
Why?
| | Infant, Newborn | 21 | 2025 | 6079 | 0.900 |
Why?
| | Child, Preschool | 24 | 2025 | 11074 | 0.890 |
Why?
| | Heart | 5 | 2023 | 655 | 0.860 |
Why?
| | Blood Flow Velocity | 9 | 2024 | 413 | 0.810 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.800 |
Why?
| | Pulmonary Valve | 3 | 2024 | 97 | 0.800 |
Why?
| | Tetralogy of Fallot | 5 | 2022 | 79 | 0.780 |
Why?
| | Coronary Circulation | 3 | 2022 | 143 | 0.760 |
Why?
| | Pulmonary Veins | 1 | 2023 | 99 | 0.750 |
Why?
| | Heart Ventricles | 8 | 2023 | 788 | 0.740 |
Why?
| | Adolescent | 38 | 2025 | 21513 | 0.730 |
Why?
| | Humans | 92 | 2025 | 137585 | 0.700 |
Why?
| | Body Surface Area | 1 | 2020 | 34 | 0.670 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 21 | 0.670 |
Why?
| | Aorta, Thoracic | 5 | 2023 | 267 | 0.670 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2020 | 382 | 0.660 |
Why?
| | Foreign Bodies | 1 | 2021 | 104 | 0.650 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2024 | 180 | 0.630 |
Why?
| | Anesthesia | 1 | 2022 | 189 | 0.610 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 534 | 0.590 |
Why?
| | Osteomyelitis | 2 | 2012 | 132 | 0.570 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 332 | 0.570 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.570 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 383 | 0.570 |
Why?
| | Male | 50 | 2025 | 67762 | 0.560 |
Why?
| | Female | 51 | 2025 | 73304 | 0.550 |
Why?
| | Pulse Wave Analysis | 7 | 2022 | 272 | 0.550 |
Why?
| | Postoperative Complications | 5 | 2020 | 2654 | 0.520 |
Why?
| | Echocardiography | 6 | 2023 | 642 | 0.520 |
Why?
| | Bronchiolitis | 1 | 2017 | 80 | 0.510 |
Why?
| | Predictive Value of Tests | 7 | 2025 | 2031 | 0.500 |
Why?
| | Scimitar Syndrome | 1 | 2016 | 9 | 0.500 |
Why?
| | Heart Rate | 1 | 2020 | 822 | 0.500 |
Why?
| | Arteries | 1 | 2018 | 269 | 0.500 |
Why?
| | Hemoptysis | 1 | 2016 | 36 | 0.490 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 114 | 0.480 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 400 | 0.470 |
Why?
| | Spermatocele | 1 | 2015 | 2 | 0.470 |
Why?
| | Cardiac Surgical Procedures | 4 | 2025 | 530 | 0.470 |
Why?
| | Ultrasonography | 3 | 2015 | 759 | 0.470 |
Why?
| | Scrotum | 1 | 2015 | 27 | 0.460 |
Why?
| | Lung Diseases, Interstitial | 2 | 2019 | 638 | 0.460 |
Why?
| | Ventricular Dysfunction, Right | 5 | 2022 | 238 | 0.460 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.460 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.450 |
Why?
| | Image Enhancement | 2 | 2022 | 190 | 0.450 |
Why?
| | Myocardium | 2 | 2017 | 1002 | 0.450 |
Why?
| | Testis | 1 | 2015 | 151 | 0.440 |
Why?
| | Pulmonary Atresia | 2 | 2025 | 21 | 0.420 |
Why?
| | Pancreatitis, Chronic | 2 | 2025 | 58 | 0.420 |
Why?
| | Fetal Heart | 2 | 2024 | 55 | 0.420 |
Why?
| | Testicular Neoplasms | 1 | 2015 | 110 | 0.420 |
Why?
| | Preoperative Care | 2 | 2017 | 362 | 0.410 |
Why?
| | Fontan Procedure | 3 | 2020 | 180 | 0.410 |
Why?
| | Stress, Mechanical | 5 | 2024 | 485 | 0.410 |
Why?
| | Phantoms, Imaging | 2 | 2024 | 152 | 0.410 |
Why?
| | Heart Valve Diseases | 3 | 2024 | 151 | 0.410 |
Why?
| | Arterial Pressure | 3 | 2019 | 126 | 0.400 |
Why?
| | Anesthesia, General | 2 | 2024 | 77 | 0.390 |
Why?
| | Community-Acquired Infections | 2 | 2012 | 174 | 0.380 |
Why?
| | Regional Blood Flow | 3 | 2024 | 474 | 0.380 |
Why?
| | Growth Plate | 1 | 2012 | 36 | 0.360 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2011 | 20 | 0.360 |
Why?
| | Aortic Valve | 3 | 2024 | 351 | 0.350 |
Why?
| | Intestinal Obstruction | 1 | 2011 | 51 | 0.340 |
Why?
| | Photons | 3 | 2025 | 70 | 0.340 |
Why?
| | Young Adult | 15 | 2024 | 13209 | 0.340 |
Why?
| | Contrast Media | 4 | 2025 | 467 | 0.340 |
Why?
| | Peritonitis | 1 | 2011 | 84 | 0.340 |
Why?
| | Lung Diseases | 2 | 2014 | 767 | 0.330 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2020 | 121 | 0.330 |
Why?
| | Myocardial Stunning | 1 | 2009 | 5 | 0.320 |
Why?
| | Aortic Diseases | 3 | 2020 | 119 | 0.320 |
Why?
| | Postoperative Care | 1 | 2011 | 261 | 0.320 |
Why?
| | Radiology | 2 | 2022 | 180 | 0.320 |
Why?
| | Cardiology | 2 | 2022 | 274 | 0.320 |
Why?
| | Coronary Vessel Anomalies | 1 | 2009 | 35 | 0.310 |
Why?
| | Aortic Arch Syndromes | 1 | 2009 | 2 | 0.310 |
Why?
| | Fetus | 3 | 2025 | 806 | 0.310 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3284 | 0.310 |
Why?
| | Heart Diseases | 2 | 2022 | 346 | 0.300 |
Why?
| | Radiography, Abdominal | 2 | 2024 | 45 | 0.300 |
Why?
| | Technetium Tc 99m Medronate | 1 | 2008 | 3 | 0.300 |
Why?
| | Diagnosis, Differential | 5 | 2018 | 1483 | 0.300 |
Why?
| | Turner Syndrome | 2 | 2019 | 54 | 0.290 |
Why?
| | Ultrasonography, Prenatal | 3 | 2025 | 285 | 0.290 |
Why?
| | Puberty, Precocious | 1 | 2008 | 13 | 0.290 |
Why?
| | Ventricular Function, Right | 5 | 2022 | 285 | 0.290 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 80 | 0.280 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 189 | 0.280 |
Why?
| | Cardiovascular Diseases | 5 | 2025 | 2111 | 0.270 |
Why?
| | Hypothyroidism | 1 | 2008 | 72 | 0.270 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2025 | 24 | 0.270 |
Why?
| | Ovary | 1 | 2008 | 221 | 0.250 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2025 | 267 | 0.250 |
Why?
| | Perfusion Imaging | 3 | 2024 | 58 | 0.240 |
Why?
| | Cardiac Catheterization | 5 | 2024 | 530 | 0.240 |
Why?
| | Artifacts | 2 | 2025 | 129 | 0.230 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 234 | 0.230 |
Why?
| | Risk | 2 | 2018 | 912 | 0.230 |
Why?
| | Treatment Outcome | 13 | 2025 | 10811 | 0.230 |
Why?
| | Greenhouse Gases | 1 | 2025 | 11 | 0.230 |
Why?
| | Biopsy | 3 | 2018 | 1129 | 0.230 |
Why?
| | Echocardiography, Four-Dimensional | 1 | 2024 | 8 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2024 | 3715 | 0.230 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 110 | 0.230 |
Why?
| | Cross-Over Studies | 2 | 2024 | 564 | 0.220 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2022 | 43 | 0.220 |
Why?
| | Respiration | 2 | 2022 | 199 | 0.220 |
Why?
| | Infant, Premature | 2 | 2023 | 574 | 0.220 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 108 | 0.220 |
Why?
| | Gestational Age | 2 | 2024 | 910 | 0.210 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 98 | 0.200 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2024 | 198 | 0.200 |
Why?
| | Prenatal Diagnosis | 1 | 2025 | 201 | 0.200 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.200 |
Why?
| | Virtual Reality | 1 | 2024 | 61 | 0.200 |
Why?
| | Heart Valve Prosthesis | 1 | 2024 | 114 | 0.200 |
Why?
| | Hepatic Veins | 1 | 2021 | 33 | 0.180 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.170 |
Why?
| | Electric Power Supplies | 1 | 2021 | 51 | 0.170 |
Why?
| | Vascular Malformations | 1 | 2021 | 52 | 0.170 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 21 | 0.170 |
Why?
| | Pediatrics | 1 | 2009 | 1101 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2025 | 752 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2019 | 3556 | 0.170 |
Why?
| | Heart Neoplasms | 1 | 2021 | 50 | 0.170 |
Why?
| | Portal Vein | 1 | 2021 | 120 | 0.170 |
Why?
| | Patient Compliance | 1 | 2024 | 581 | 0.170 |
Why?
| | Sarcopenia | 1 | 2021 | 83 | 0.160 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 82 | 0.160 |
Why?
| | Pulmonary Circulation | 2 | 2019 | 429 | 0.160 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.160 |
Why?
| | Gastric Bypass | 1 | 2021 | 119 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 118 | 0.160 |
Why?
| | Follow-Up Studies | 4 | 2021 | 5131 | 0.160 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 225 | 0.160 |
Why?
| | Sensitivity and Specificity | 3 | 2024 | 1946 | 0.160 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.160 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.150 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.150 |
Why?
| | Cardiovascular Abnormalities | 1 | 2019 | 13 | 0.150 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2020 | 131 | 0.150 |
Why?
| | Kidney | 3 | 2022 | 1468 | 0.150 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 198 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2018 | 41 | 0.150 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 18 | 0.150 |
Why?
| | Eating | 1 | 2021 | 380 | 0.150 |
Why?
| | Cloaca | 1 | 2018 | 48 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 124 | 0.140 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 259 | 0.140 |
Why?
| | Shear Strength | 1 | 2018 | 67 | 0.140 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 64 | 0.140 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 106 | 0.140 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.140 |
Why?
| | Liver Function Tests | 1 | 2018 | 114 | 0.140 |
Why?
| | Sleep | 1 | 2024 | 755 | 0.140 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 23 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2021 | 264 | 0.140 |
Why?
| | Blood Vessels | 1 | 2018 | 187 | 0.130 |
Why?
| | Stroke Volume | 4 | 2022 | 612 | 0.130 |
Why?
| | Cholangitis, Sclerosing | 1 | 2018 | 75 | 0.130 |
Why?
| | Prospective Studies | 7 | 2024 | 7604 | 0.130 |
Why?
| | Thoracic Diseases | 1 | 2016 | 14 | 0.130 |
Why?
| | Perfusion | 1 | 2017 | 213 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2531 | 0.130 |
Why?
| | Vascular Remodeling | 1 | 2018 | 193 | 0.130 |
Why?
| | Prognosis | 5 | 2021 | 4030 | 0.130 |
Why?
| | Dilatation, Pathologic | 3 | 2024 | 62 | 0.130 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 37 | 0.130 |
Why?
| | Systole | 3 | 2022 | 189 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 229 | 0.120 |
Why?
| | Quality Improvement | 1 | 2024 | 1178 | 0.120 |
Why?
| | Prevalence | 1 | 2023 | 2734 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 915 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2022 | 611 | 0.120 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 316 | 0.120 |
Why?
| | Age Factors | 5 | 2024 | 3295 | 0.120 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 552 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 331 | 0.110 |
Why?
| | Calcinosis | 1 | 2017 | 235 | 0.110 |
Why?
| | Mutation | 2 | 2024 | 3958 | 0.110 |
Why?
| | Adult | 11 | 2025 | 37929 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 625 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2017 | 696 | 0.110 |
Why?
| | Risk Assessment | 4 | 2018 | 3457 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5778 | 0.110 |
Why?
| | Toes | 1 | 2014 | 14 | 0.110 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 27 | 0.110 |
Why?
| | Research Design | 1 | 2020 | 1139 | 0.100 |
Why?
| | Liver Transplantation | 1 | 2021 | 871 | 0.100 |
Why?
| | Disease Progression | 2 | 2018 | 2757 | 0.100 |
Why?
| | Edema | 1 | 2014 | 130 | 0.100 |
Why?
| | Ligation | 1 | 2012 | 92 | 0.100 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 28 | 0.100 |
Why?
| | Reference Values | 2 | 2024 | 816 | 0.100 |
Why?
| | Comorbidity | 1 | 2017 | 1622 | 0.100 |
Why?
| | Surgical Instruments | 1 | 2012 | 51 | 0.100 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2012 | 52 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1692 | 0.090 |
Why?
| | Gadolinium DTPA | 1 | 2012 | 70 | 0.090 |
Why?
| | Barium Sulfate | 1 | 2011 | 15 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5472 | 0.090 |
Why?
| | North America | 2 | 2022 | 313 | 0.090 |
Why?
| | Biomechanical Phenomena | 3 | 2020 | 810 | 0.090 |
Why?
| | Lung | 2 | 2023 | 4060 | 0.090 |
Why?
| | Consensus | 2 | 2025 | 683 | 0.090 |
Why?
| | Bronchi | 1 | 2012 | 260 | 0.090 |
Why?
| | Colonography, Computed Tomographic | 1 | 2010 | 8 | 0.090 |
Why?
| | American Heart Association | 2 | 2022 | 306 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 698 | 0.080 |
Why?
| | Glomerulonephritis, IGA | 1 | 2009 | 11 | 0.080 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 40 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1291 | 0.080 |
Why?
| | Ventricular Remodeling | 2 | 2022 | 266 | 0.070 |
Why?
| | Adnexal Diseases | 1 | 2008 | 2 | 0.070 |
Why?
| | Ovarian Cysts | 1 | 2008 | 6 | 0.070 |
Why?
| | Myocardial Contraction | 2 | 2020 | 341 | 0.070 |
Why?
| | Age Determination by Skeleton | 1 | 2008 | 18 | 0.070 |
Why?
| | Pericardial Effusion | 1 | 2008 | 19 | 0.070 |
Why?
| | Middle Aged | 6 | 2024 | 33479 | 0.070 |
Why?
| | Bacteremia | 1 | 2010 | 214 | 0.070 |
Why?
| | Pregnancy | 4 | 2025 | 6763 | 0.070 |
Why?
| | Thyroid Hormones | 1 | 2008 | 61 | 0.070 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 178 | 0.070 |
Why?
| | Pleural Effusion | 1 | 2008 | 54 | 0.070 |
Why?
| | Thyroid Gland | 1 | 2008 | 94 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1046 | 0.070 |
Why?
| | Pelvis | 1 | 2008 | 102 | 0.070 |
Why?
| | Syndrome | 1 | 2008 | 358 | 0.070 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 167 | 0.070 |
Why?
| | Puberty | 1 | 2008 | 146 | 0.060 |
Why?
| | Carbon Footprint | 1 | 2025 | 2 | 0.060 |
Why?
| | Hemorrhage | 1 | 2009 | 722 | 0.060 |
Why?
| | Blood Circulation | 1 | 2024 | 41 | 0.060 |
Why?
| | Motion | 1 | 2025 | 99 | 0.060 |
Why?
| | Aortic Aneurysm | 1 | 2024 | 64 | 0.050 |
Why?
| | Time Factors | 3 | 2021 | 6828 | 0.050 |
Why?
| | Body Size | 1 | 2024 | 108 | 0.050 |
Why?
| | Risk Factors | 4 | 2021 | 10388 | 0.050 |
Why?
| | Workflow | 1 | 2025 | 165 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 110 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 30 | 0.050 |
Why?
| | Observer Variation | 1 | 2023 | 343 | 0.050 |
Why?
| | Climate Change | 1 | 2025 | 183 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 310 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2828 | 0.050 |
Why?
| | Prosthesis Design | 1 | 2024 | 327 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 815 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.040 |
Why?
| | United States | 3 | 2024 | 14841 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 499 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 69 | 0.040 |
Why?
| | Iron-Binding Proteins | 1 | 2000 | 44 | 0.040 |
Why?
| | Norwood Procedures | 1 | 2020 | 29 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1007 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 138 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 1060 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1809 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 41 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 58 | 0.040 |
Why?
| | Cation Transport Proteins | 1 | 2000 | 134 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 195 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 149 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 145 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 688 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1993 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 84 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 4149 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 44 | 0.040 |
Why?
| | Waiting Lists | 1 | 2021 | 266 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 746 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 90 | 0.040 |
Why?
| | Biliary Tract | 1 | 2018 | 17 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 153 | 0.040 |
Why?
| | Incidence | 2 | 2018 | 2804 | 0.040 |
Why?
| | Societies, Medical | 1 | 2022 | 820 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1236 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 82 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2019 | 137 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2019 | 375 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 470 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1710 | 0.030 |
Why?
| | Cardiac Output | 1 | 2017 | 165 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 513 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1704 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 771 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1477 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 59 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 931 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 224 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 124 | 0.030 |
Why?
| | Triplets | 1 | 2012 | 3 | 0.020 |
Why?
| | Pregnancy, Multiple | 1 | 2012 | 17 | 0.020 |
Why?
| | Blood Pressure | 1 | 2019 | 1786 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 270 | 0.020 |
Why?
| | Angiography | 1 | 2012 | 207 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2012 | 223 | 0.020 |
Why?
| | Cesarean Section | 1 | 2012 | 184 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 463 | 0.020 |
Why?
| | Ireland | 1 | 2010 | 30 | 0.020 |
Why?
| | Airway Obstruction | 1 | 2012 | 162 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1208 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2389 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 573 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 318 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2009 | 86 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1943 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1430 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2992 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 405 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 496 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2009 | 435 | 0.020 |
Why?
| | Aged | 2 | 2019 | 23961 | 0.010 |
Why?
| | COS Cells | 1 | 2000 | 188 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 140 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 363 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 560 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 945 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7635 | 0.010 |
Why?
| | Rats | 1 | 2000 | 5647 | 0.010 |
Why?
| | Mice | 1 | 2000 | 17787 | 0.000 |
Why?
| | Animals | 1 | 2000 | 36940 | 0.000 |
Why?
|
|
Browne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|